Pfizer gets early FTC clearance for Metsera acquisition Oct 31, 2025 03:51PM
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition Oct 31, 2025 03:50PM
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030 Jun 18, 2025 08:45AM
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences Jun 11, 2025 08:30AM
Guardant Health (GH) Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform Apr 24, 2025 08:05AM
View Older Stories

Apr 24, 2025 08:05AM Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform
Feb 24, 2025 08:13PM Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
Dec 18, 2024 08:45AM Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Nov 21, 2024 04:00AM Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)
Sep 20, 2024 09:00AM How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
Sep 4, 2024 08:30AM Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
Aug 6, 2024 08:30AM Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033   
Jul 25, 2024 08:30AM Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
Jul 10, 2024 05:22AM Evotec SE (EVO) and Pfizer Collaborate to Advance Drug Discovery in France
Jun 5, 2024 04:05PM Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
May 24, 2024 08:45AM Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 8, 2024 08:30AM Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
Apr 11, 2024 10:00AM Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Mar 20, 2024 10:00AM Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts
Mar 5, 2024 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Feb 29, 2024 08:01AM Pfizer (PFE) Reports Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO
Feb 29, 2024 08:00AM Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
Feb 26, 2024 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Feb 15, 2024 10:00AM Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day
Feb 15, 2024 08:45AM Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
Feb 14, 2024 08:30AM Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
Feb 5, 2024 10:00AM Breaking Barriers in Cancer Care: The American Cancer Society and Pfizer Announce a $15 Million, Three-Year Initiative to Bridge the Gap in Cancer Care Disparities
Jan 10, 2024 04:30PM Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
Jan 9, 2024 06:45AM Pfizer (PFE) and Genmab (GMAB) Reports TIVDAK sBLA Accepted for Priority Review by FDA
Jan 9, 2024 06:45AM TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer
Jan 9, 2024 06:45AM TIVDAK® Supplemental Biologics License Application Accepted for Priority Review by FDA for Patients with Recurrent or Metastatic Cervical Cancer
Jan 2, 2024 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Dec 19, 2023 10:00AM Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts
Dec 14, 2023 04:30PM Pfizer Declares First-Quarter 2024 Dividend
Dec 14, 2023 07:39AM Pfizer (PFE) Completes Acquisition of Seagen (SGEN)
Dec 14, 2023 07:39AM Pfizer Completes Acquisition of Seagen
Dec 12, 2023 06:45AM Pfizer (PFE) Receives Approvals to Complete the Acquisition of Seagen
Dec 12, 2023 06:45AM Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
Dec 11, 2023 04:30PM Pfizer (PFE) Announces FDA and EMA Acceped Marstacimab Regulatory Submissions for the Treatment of Hemophilia A and B
Dec 11, 2023 04:30PM FDA and EMA Accept Marstacimab Regulatory Submissions for the Treatment of Hemophilia A and B
Dec 11, 2023 03:58AM Pfizer (PFE) Presents New Marstacimab Phase 3 Data Showing Significant Bleed Reduction in Hemophilia A and B
Dec 9, 2023 07:00PM Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B
Dec 8, 2023 07:55AM Pfizer (PFE) Announces European Commission Approves ELREXFIO for Relapsed and Refractory Multiple Myeloma
Dec 8, 2023 07:55AM European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma
Dec 5, 2023 01:36PM Arvinas (ARVN) and Pfizer (PFE) Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE)
Dec 5, 2023 01:33PM Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) and Plans to Expand Vepdegestrant Development Program
Dec 4, 2023 04:20PM Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15
Dec 1, 2023 06:53AM Pfizer (PFE) announced Phase 2B trial of danuglipron showed statistically significant reductions from baseline in body weight for all doses
Dec 1, 2023 06:45AM Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity
Nov 28, 2023 05:05PM Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium
Nov 21, 2023 10:00AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Nov 2, 2023 10:52AM Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting
Nov 2, 2023 10:00AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Oct 26, 2023 06:45AM Pfizer (PFE) and BioNTech (BNTX) Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Oct 26, 2023 06:45AM Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
View Older Stories